Various studies have shown that GHRH-R antagonists of the MIAMI series, such as MIA-602 and MIA-690, successfully reduce tumour cell proliferation as well as tumour growth of CRPC cell xenografts in animals [16,17,18,19,20]. This evidence concerns the gene GHRHR and neoplasm.